£100
No changevs Sept 2024Active13644943Private limited companyOxford
PHARMEDOX LIMITED
Significant control: Keith Alfred Moyse (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Pharmedox Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
PHARMEDOX LIMITED is an active private limited company (company number 13644943) incorporated on 27 September 2021, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 September 2025, showing net assets of £100 and cash of £100. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Dr. Keith Alfred Moyse
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 27 September 20215 yrs ago
- Next accounts due
- 30 June 2027in 250 days
- Confirmation statement due
- 11 October 2027in 353 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
£100
No changevs Sept 2024Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £100 | £100 | — | — | — | — | — |
| 30 September 2024 | £100 | £100 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £100 at 30 September 2025
- Incorporated five or more years agoIncorporated 27 September 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 353 days
- Next accounts duein 250 days
- Accounts period endNet assets £100 · dormant accounts
- Accounts period endNet assets £100 · dormant accounts
- Incorporated
08
Similar companies in Oxford
- INFINITOPES LIMITEDOxford · inc. Sept 2021
- THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITEDOxford · inc. Oct 2021
- NEOVAC LTDAbingdon · inc. Sept 2021
- UNEQUAL LTDOxford · inc. Sept 2021
- ABGERRY LTDDidcot · inc. Nov 2021
- REMEDY RX LTDOxford · inc. Nov 2021
All companies incorporated on 27 September 2021 · in Sept 2021.
09
Reminders for PHARMEDOX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.